View Mobile Friendly Conference List »

Setting new standards in information exchange for the pharmaceutical and biotech industry

Blog

Conference Forum Hosts Clinical Research as a Care Option (CRAACO) Roundtable at DPharm


  • September 5, 2016

  • Eli Lilly's Katherine Vandebelt hosting DPharm 2015 session with Wilmington Health, CEO Jeff James and PMG Research's CEO, Jennifer Byrne.

    Eli Lilly’s Katherine Vandebelt hosting DPharm 2015 session with Wilmington Health, CEO Jeff James and PMG Research’s CEO, Jennifer Byrne.

    New York, NY, the Conference Forum announced they are hosting the 2nd Clinical Research as a Care Option (CRAACO) round table at DPharm on September 21st at 12:30 in Boston. A diverse group of stakeholders representing healthcare, pharma, technology and policy agents come together to discuss the integration of research and care to optimize patient care delivery within a value-based healthcare system. The key objective is to gather like-minded/progressive participants for an interactive discussion, with the ultimate goal of encouraging a movement to bridge research as continuum of patient care- transforming patient care/research delivery model. This discussion builds on the work initiated by Eli Lilly, PMG Research and Wilmington Health in building evidence of the value of research participation.

    Katherine Vandebelt, Global Head, Clinical Innovation, Eli Lilly & Company and Craig Lipset, Head of Clinical Innovation, R&D, Pfizer are co-moderating the roundtable session and will seek the support from the CRAACO team to navigate the discussion.
    We look forward to discussing highlights and next steps post the meeting.

    CRAACO 2015 Group Meeting

    CRAACO 2015 Group Meeting